Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CADOUX LIMITED Director's Dealing 2007

Sep 12, 2007

64620_rns_2007-09-12_6b74eb26-ef4d-4726-be90-fad108b063c2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entitySolbec Pharmaceuticals Ltd
ABN 85 061 289 218

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Grant Karl Maynard BENNETT
Date of last notice 13thSeptember 2007

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. AMB Holdings Pty Ltd(Director shareholder)
Date of change 6 September 2007
No. of securities held prior to change 4,844,286 Ordinary Shares (direct)255,413 Ordinary Shares (indirect)
Class Ordinary Shares and Options
Number acquired 10,000,000 Options expiring 30/06/2010exercisable at 0.7cents
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation Nil
No. of securities held after change 4,844,286Ordinary Shares (direct)255,413 Ordinary Shares (indirect)10,000,000 Options expiring 30/06/2010exercisable at 0.7cents (indirect)
Nature of changeExample: on-market trade, off-market trade, exercise of options,issueofsecuritiesunderdividendreinvestmentplan,participation in buy-back 10,000,000 options received in consideration forfinancing facility
  • See chapter 19 for defined terms.

30/9/2001

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

  • See chapter 19 for defined terms.

30/9/2001

Appendix 3Y Page 2